Sekhmet Pharmaventures Profile
Key Indicators
- Authorised Capital ₹ 2,250.00 Cr
as on 09-11-2024
- Paid Up Capital ₹ 1,817.26 Cr
as on 09-11-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 166.83%
(FY 2023)
- Profit -90.82%
(FY 2023)
- Ebitda -83.78%
(FY 2023)
- Net Worth 11006.22%
(FY 2023)
- Total Assets 497.00%
(FY 2023)
About Sekhmet Pharmaventures
The Corporate was formerly known as Stepahead Business Services Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2,250.00 Cr and a paid-up capital of Rs 1,817.26 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sekhmet Pharmaventures Private Limited India is Anil Khubchandani as CEO. Vivek Chhachhi, Srinivasareddy Desireddy, Anchit Gupta, and Three other members serve as directors at the Company.
- CIN/LLPIN
U74999MH2020PTC340954
- Company No.
340954
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jun 2020
- Date of AGM
26 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sekhmet Pharmaventures?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Khubchandani  | Managing Director | 20-Jun-2023 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vivek Chhachhi | Director | 04-Dec-2020 | Current |
| Srinivasareddy Desireddy | Director | 26-Oct-2022 | Current |
| Anchit Gupta | Director | 04-Dec-2020 | Current |
| Nikhilkumar Srivastava | Director | 03-Oct-2020 | Current |
| Aswin Vikram | Director | 28-Oct-2022 | Current |
Financial Performance and Corporate Structure Insights of Sekhmet Pharmaventures.
Sekhmet Pharmaventures Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 166.83% increase. The company also saw a substantial fall in profitability, with a 90.82% decrease in profit. The company's net worth Soared by an impressive increase of 11006.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sekhmet Pharmaventures?
In 2023, Sekhmet Pharmaventures had a promoter holding of 100.00%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Optimus Drugs Private LimitedActive 21 years 18 daysSrinivasareddy Desireddy and Anil Khubchandani are mutual person
- Optimus Pharma Private LimitedActive 20 years 2 months
Srinivasareddy Desireddy and Anil Khubchandani are mutual person
Acme Formulation Private LimitedActive 20 years 6 monthsNikhilkumar Srivastava and Aswin Vikram are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sekhmet Pharmaventures?
Sekhmet Pharmaventures has a workforce of 12 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sekhmet Pharmaventures, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sekhmet Pharmaventures's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
